Stentys has released in Europe an enhanced stent-delivery system for its Self-Apposing Stent used in the treatment of acute myocardial infarction (AMI).
The new catheter to implant the Stentys Self-Apposing Stent adds a hydrophilic (slippery) coating and an ergonomic handle that considerably facilitates stent implantation in tortuous vessels.
In its latest guidelines on AMI treatment, the European Society of Cardiology (ESC) calls attention to the importance of selecting the appropriate stent size, as the vessel in this setting is contracted and contains thrombus, and to the complications that may result from inappropriate stent sizing. According to a company release, the Stentys Self-Apposing Stent solves that “stent-sizing dilemma” fitting into the contour of a blood vessel, and its shape and diameter adapt as the vessel dilates and the initial clot dissolves during the post-AMI phase.
“Feedback from cardiologists suggests the new delivery catheter is very user-friendly and we are confident this product enhancement will allow a greater range of patients to benefit from our Stentys Self-Apposing Stent technology,” said Gonzague Issenmann, CEO and co-founder of Stentys.
